ESMO 2024: Targeting the Treatment Challenges of Small Cell Lung Cancer - Episode 1

Current Landscape of First-Line Treatment for Limited-Stage SCLC: Diagnostic Workup & Multidisciplinary Approaches

September 30, 2024

Melissa L. Johnson, MD, Wade T. Iams, MD, Ticiana A. Leal, MD, Triparna Sen, PhD

Panelists discuss how the current landscape of first-line treatment for limited-stage small cell lung cancer is shaped by various clinical factors that influence the diagnostic workup and management, emphasizing the importance of a multidisciplinary team approach in developing effective treatment plans for these patients.

Now Viewing

EP. 1: Current Landscape of First-Line Treatment for Limited-Stage SCLC: Diagnostic Workup & Multidisciplinary Approaches

EP. 2: Surgical and Radiotherapy Choices in Limited-Stage SCLC

Video content above is prompted by the following:

Briefly explore the current landscape of first-line treatmentfor limited-stage small cell lung cancer (LS-SCLC):

What clinical factors influence the initial diagnostic workup and managementof patients with LS-SCLC?
To what degree is a multidisciplinary team approach adopted when developing a treatment plan for patients with LS-SCLC?